-+ 0.00%
-+ 0.00%
-+ 0.00%

NeurAxis Q2 net loss widens 23.4% to $2.09 million year over year; net sales more than double to $1.93 million year over year

PUBT·08/11/2026 11:05:50
Listen to the news
NeurAxis Q2 net loss widens 23.4% to $2.09 million year over year; net sales more than double to $1.93 million year over year
  • NeurAxis posted a GAAP net loss of USD 2.09 million for Q2 2026, widening 23.4% year over year.
  • Net sales more than doubled to USD 1.93 million, up 115.7% year over year.
  • Gross margin rose to 85.9%, up 2.3 percentage points from a year earlier.
  • Cash and cash equivalents climbed to USD 8.32 million at June 30, 2026, from USD 4.97 million at Dec. 31, 2025.
  • Sales growth was attributed to broader insurance coverage tied to IB-Stim’s Category I CPT code effective Jan. 1, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NeurAxis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-036978), on August 11, 2026, and is solely responsible for the information contained therein.